{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-09-04&max-date=2014-10-21&answer.answeringMemberPrinted=Jane+Ellison&max-answer.questionFirstAnswered.=2014-09-04T14%3A21%3A02.8013433Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.dateOfAnswer=2014-09-04&max-date=2014-10-21&answer.answeringMemberPrinted=Jane+Ellison&max-answer.questionFirstAnswered.=2014-09-04T14%3A21%3A02.8013433Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-09-04&max-date=2014-10-21&_metadata=all&answer.answeringMemberPrinted=Jane+Ellison&max-answer.questionFirstAnswered.=2014-09-04T14%3A21%3A02.8013433Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.dateOfAnswer=2014-09-04&max-date=2014-10-21&answer.answeringMemberPrinted=Jane+Ellison&max-answer.questionFirstAnswered.=2014-09-04T14%3A21%3A02.8013433Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-09-04&max-date=2014-10-21&answer.answeringMemberPrinted=Jane+Ellison&max-answer.questionFirstAnswered.=2014-09-04T14%3A21%3A02.8013433Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-09-04&max-date=2014-10-21&answer.answeringMemberPrinted=Jane+Ellison&max-answer.questionFirstAnswered.=2014-09-04T14%3A21%3A02.8013433Z", "items" : [{"_about" : "http://data.parliament.uk/resources/79388", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/79388/answer", "answerText" : {"_value" : "<p>Reports of \u2018suspected\u2019 adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines through the spontaneous reporting scheme; the Yellow Card Scheme. The scheme collects ADR reports from across the whole United Kingdom and includes all medicines, including those from prescriptions, over-the-counter or general retail sales. Reports are also received for herbal medicines and other unlicensed medicines.<\/p><p>There is unknown and a variable level of under-reporting to the Yellow Card Scheme meaning that data collected cannot be used to calculate incidence, as such we cannot provide the number of serious health events per thousand. We are unable to calculate this incidence because neither the total number of reactions occurring in the population, nor the number of patients using the drug is known.<\/p><p>The following table shows the total number of serious UK spontaneous \u2018suspected\u2019 ADR reports received by the MHRA between 23 July 2013 and 22 July 2014 broken down for E-Cigarettes, Nicotine Replacement Therapies (excluding E-Cigarettes) and Varenicline:<\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>Total Serious Reports<\/p><\/td><\/tr><tr><td><p>Varenicline<\/p><\/td><td><p>297<\/p><\/td><\/tr><tr><td><p>Nicotine Replacement therapy<\/p><\/td><td><p>75<\/p><\/td><\/tr><tr><td><p>E-Cigarettes<\/p><\/td><td><p>5<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T13:15:22.548935Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Smoking"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how many serious health events have been recorded per thousand (a) e-cigarette users, (b) users of nicotine replacement therapies and (c) users of the Champix form of varenicline in the last year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1545", "label" : {"_value" : "Biography information for David T C Davies"}
      }
      , "tablingMemberConstituency" : {"_value" : "Monmouth"}
      , "tablingMemberPrinted" : [{"_value" : "David T. C. Davies"}
      ], "uin" : "206979"}
    , {"_about" : "http://data.parliament.uk/resources/78989", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/78989/answer", "answerText" : {"_value" : "<p>The Government has not yet made a final decision on whether to introduce standardised packaging for tobacco products. We held a United Kingdom-wide consultation on introducing regulations for standardised packaging of tobacco products, which ran from 26 June to 7 August. The consultation asked for new and relevant information that would help in assessing the wider impact of plain packaging, including economic and other considerations.<\/p><p>The consultation included draft regulations so it is clear how requirements for standardised packaging would work in practice. Alongside the consultation, we have also published an updated consultation-stage Impact Assessment. The consultation asked respondents for further evidence or information which would improve the assumptions or estimates made in the Impact Assessment.<\/p><p>The Government does not intend to run any further consultations with regard to standardised packaging.<\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "206715"}
        , {"_value" : "206788"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T14:21:02.7308578Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Tobacco: Packaging"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, when his Department plans to conduct its consultation on the potential effect of standardised packaging of tobacco on the small retail sector; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"}
      }
      , "tablingMemberConstituency" : {"_value" : "Broxbourne"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Charles Walker"}
      ], "uin" : "206716"}
    , {"_about" : "http://data.parliament.uk/resources/78994", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/78994/answer", "answerText" : {"_value" : "<p>The Government has not yet made a final decision on whether to introduce standardised packaging for tobacco products. We held a United Kingdom-wide consultation on introducing regulations for standardised packaging of tobacco products, which ran from 26 June to 7 August. The consultation asked for new and relevant information that would help in assessing the wider impact of plain packaging, including economic and other considerations.<\/p><p>The consultation included draft regulations so it is clear how requirements for standardised packaging would work in practice. Alongside the consultation, we have also published an updated consultation-stage Impact Assessment. The consultation asked respondents for further evidence or information which would improve the assumptions or estimates made in the Impact Assessment.<\/p><p>The Government does not intend to run any further consultations with regard to standardised packaging.<\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "206715"}
        , {"_value" : "206716"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T14:21:02.8013433Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Tobacco: Packaging"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, if his Department will conduct a consultation on the potential effect of standardised packaging of tobacco on down-trading to cheaper products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"}
      }
      , "tablingMemberConstituency" : {"_value" : "Broxbourne"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Charles Walker"}
      ], "uin" : "206788"}
    , {"_about" : "http://data.parliament.uk/resources/78995", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/78995/answer", "answerText" : {"_value" : "<p>Health ministers have not had any specific discussions about standardised packaging of tobacco with ministers from New Zealand.<\/p><p>Departmental officials occasionally receive updates from the New Zealand Ministry of Health regarding plans in that country for the introduction of requirements for standardised packaging.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T13:02:08.2227558Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Tobacco: Packaging"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what discussions he has had with his counterpart in New Zealand on the standardising of tobacco packaging.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"}
      }
      , "tablingMemberConstituency" : {"_value" : "Broxbourne"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Charles Walker"}
      ], "uin" : "206787"}
    , {"_about" : "http://data.parliament.uk/resources/79004", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/79004/answer", "answerText" : {"_value" : "<p>The Government has not yet made a final decision on whether to introduce standardised packaging for tobacco products. We held a United Kingdom-wide consultation on introducing regulations for standardised packaging of tobacco products, which ran from 26 June to 7 August. The consultation asked for new and relevant information that would help in assessing the wider impact of plain packaging, including economic and other considerations.<\/p><p>The consultation included draft regulations so it is clear how requirements for standardised packaging would work in practice. Alongside the consultation, we have also published an updated consultation-stage Impact Assessment. The consultation asked respondents for further evidence or information which would improve the assumptions or estimates made in the Impact Assessment.<\/p><p>The Government does not intend to run any further consultations with regard to standardised packaging.<\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "206716"}
        , {"_value" : "206788"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T14:21:02.6683606Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Tobacco: Packaging"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, if his Department will conduct a consultation, separate to that carried out by the Department for Business, Innovation and Skills on the potential effect of standardised packaging of tobacco on the Government's long-term economic plan.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"}
      }
      , "tablingMemberConstituency" : {"_value" : "Broxbourne"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Charles Walker"}
      ], "uin" : "206715"}
    , {"_about" : "http://data.parliament.uk/resources/79044", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/79044/answer", "answerText" : {"_value" : "<p>We have been advised by the Food Standards Agency that in accordance with European Union legislation, all consignments of meat, imported into the United Kingdom (UK) must be presented for official controls at designated Border Inspection Posts (BIPs) in the UK. All consignments must undergo documentary and identity checks to ensure they are the products attested in the required animal and public health certificate accompanying each consignment. In addition, 20% of all meat, including offal, and products of the bovine, ovine, caprine, porcine and equine species, passing through the BIP, must undergo a physical check, which may include a laboratory test. This rate is increased to 50% for poultry, rabbit and game meat. We have no reports of imported fat being presented as meat products from these controls.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T13:38:28.5653059Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Fats: Imports"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what system his Department has put in place to carry out sample checks on imported fat; and what assessment he has made of the risks of imported fat being passed off as a meat product.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1476", "label" : {"_value" : "Biography information for Huw Irranca-Davies"}
      }
      , "tablingMemberConstituency" : {"_value" : "Ogmore"}
      , "tablingMemberPrinted" : [{"_value" : "Huw Irranca-Davies"}
      ], "uin" : "206747"}
    , {"_about" : "http://data.parliament.uk/resources/79061", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/79061/answer", "answerText" : {"_value" : "<p> <\/p><p>Public Health England do not routinely present diabetes data by parliamentary constituency. It has produced estimates of the total number of adults with diabetes (diagnosed and undiagnosed). Across England it was estmated that there were 3,141,622 adults with diabetes (diagnosed and undiagnosed) in 2012. The estimates for 2013 and 2014 were 3,211,368 and 3,279,925 respectively. It was estimated that in Torbay Unitary Authority the total number of adults with diabetes (diagnosed and undiagnosed) was 9,589 in 2012, 9,773 in 2013 and 9,947 in 2014.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The Quality and Outcomes Framework provides data on the total number of adults aged 17 years and older who have diagnosed diabetes. This showed that in 2012 there were 2,566,436 adults with diagnosed diabetes in England. By 2013 this had increased to 2,703,044. It is not possible to provide local data for consistent areas for recent years. In 2013 there were 14,485 adults with diagnosed diabetes in South Devon and Torbay Clinical Commissioning Group. However, this covers a larger area than Torbay Unitary Authority.<\/p><p> <\/p><p> <\/p><p>The National Cardiovascular Intelligence Network will be publishing cardiovascular disease profiles by clinical commissioning group in August 2014 which will include a chapter about diabetes. These will bring together a number of key indicators about diabetes.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T13:44:27.3244927Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Diabetes"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how many people were (a) diagnosed with and (b) living with diabetes in (i) Torbay constituency and (ii) England in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/237", "label" : {"_value" : "Biography information for Mr Adrian Sanders"}
      }
      , "tablingMemberConstituency" : {"_value" : "Torbay"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Adrian Sanders"}
      ], "uin" : "206783"}
    , {"_about" : "http://data.parliament.uk/resources/79065", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/79065/answer", "answerText" : {"_value" : "<p> <\/p><p>National Health Service trusts and foundation trusts do not receive the majority of their funding directly from the Department. They are semi-autonomous organisations whose income derives from the provision of services to NHS England and clinical commissioning groups.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The Department did however provide public dividend capital to both organisations in 2013-14 to support a number of centrally-led initiatives, shown in the following table:<\/p><p> <\/p><p> <\/p><p> <\/p><table><tbody><tr><td><p> <\/p><\/td><td><p>Lancashire Teaching Hospitals<br> NHS Foundation Trust <br> £000s<\/p><\/td><td><p>Lancashire Care NHS<br> Foundation Trust<br> £000s<\/p><\/td><\/tr><tr><td><p>Dementia care<\/p><\/td><td><p>1,014<\/p><\/td><td><p>-<\/p><\/td><\/tr><tr><td><p>Improving birth environments<\/p><\/td><td><p>754<\/p><\/td><td><p>-<\/p><\/td><\/tr><tr><td><p>Nursing and technology fund<\/p><\/td><td><p>162<\/p><\/td><td><p>358<\/p><\/td><\/tr><tr><td><p>Improving maternity care settings<\/p><\/td><td><p>52<\/p><\/td><td><p>-<\/p><\/td><\/tr><tr><td><p>Integrated digital care fund<\/p><\/td><td><p>-<\/p><\/td><td><p>403<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>1,982<\/p><\/td><td><p>761<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The Department additionally provided public dividend capital in previous years as set out in the following table. The purpose of these allocations was not collected centrally prior to 2013-14.<\/p><p> <\/p><p> <\/p><p> <\/p><table><tbody><tr><td><p> <\/p><\/td><td><p>Lancashire Teaching Hospitals<br> NHS Foundation Trust<br> £000s<\/p><\/td><td><p>Lancashire Care NHS<br> Foundation Trust<br> £000s<\/p><\/td><\/tr><tr><td><p>2012-13<\/p><\/td><td><p>-<\/p><\/td><td><p>624<\/p><\/td><\/tr><tr><td><p>2011-12<\/p><\/td><td><p>-<\/p><\/td><td><p>-<\/p><\/td><\/tr><tr><td><p>2010-11<\/p><\/td><td><p>-<\/p><\/td><td><p>900<\/p><\/td><\/tr><tr><td><p>2009-10<\/p><\/td><td><p>-<\/p><\/td><td><p>-<\/p><\/td><\/tr><tr><td><p>2008-09<\/p><\/td><td><p>3,888<\/p><\/td><td><p>-<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>3,888<\/p><\/td><td><p>1,524<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T13:42:20.8297461Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Health Services: Lancashire"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much funding his Department provided to (a) Lancashire Teaching Hospitals NHS Foundation Trust and (b) Lancashire Care NHS Foundation Trust in each of the last six years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/473", "label" : {"_value" : "Biography information for Sir Mark Hendrick"}
      }
      , "tablingMemberConstituency" : {"_value" : "Preston"}
      , "tablingMemberPrinted" : [{"_value" : "Mark Hendrick"}
      ], "uin" : "206732"}
    , {"_about" : "http://data.parliament.uk/resources/79071", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/79071/answer", "answerText" : {"_value" : "<p> <\/p><p>The Department has been reviewing policy on addiction to prescription medicine over this period, and the Government\u2019s Drug Strategy, published in December 2010, highlights our commitment to reduce dependence on prescription and over the counter medicines.<\/p><p> <\/p><p> <\/p><p> <\/p><p>In 2009, the Department identified a lack of information on this important subject. The Department commissioned a literature review from the National Addiction Centre and a report from the National Treatment Agency for Substance Misuse (NTA) which interrogated data on specialist treatment and surveyed local commissioners and specialist treatment providers. These reports were peer reviewed and published in May 2011. The cost to the Department for the National Addiction Centre literature review was £9,750 and the cost for the NTA review was £80,000.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The reports informed the discussions of roundtable meetings of expert stakeholders which were convened by the Minister for Public Health to agree action to tackle addiction to medicines. The roundtable produced a consensus statement, endorsed by the Royal College of General Practitioners, the Royal College of Psychiatrists and other organisations which was published in January 2013. The only direct cost to the Department concerning the roundtables, and other meetings, was £1,928.09 in travel expenses for non-Departmental staff.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Other Departmental costs associated with reviewing policy on addiction to prescription medicine are not separately identifiable.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Public Health England (PHE) organised a seminar in February 2013 to improve the commissioning of services to treat addiction to medicine, and following the seminar, in June 2013 published a guide for the National Health Service and local authorities on commissioning treatment for dependence on prescription and over-the-counter medicines.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The Medicines and Healthcare products Regulatory Agency published in March 2013 a learning module on benzodiazepines which includes advice for prescribers on preventing and treating dependence on these medicines.<\/p><p> <\/p><p> <\/p><p> <\/p><p>In July 2014, with the approval of the Department and the devolved administrations, PHE launched a public consultation on whether there should be an update to the 2007 United Kingdom clinical guidelines on drug misuse and dependence. The guidelines include advice on treating dependence on benzodiazepines.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T13:40:04.8773287Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescription Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what steps his Department has taken since 2009 to review policy on addiction to prescription medication; and what the total identifiable costs have been of this review process.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4141", "label" : {"_value" : "Biography information for Eric Ollerenshaw"}
      }
      , "tablingMemberConstituency" : {"_value" : "Lancaster and Fleetwood"}
      , "tablingMemberPrinted" : [{"_value" : "Eric Ollerenshaw"}
      ], "uin" : "206669"}
    , {"_about" : "http://data.parliament.uk/resources/79076", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/79076/answer", "answerText" : {"_value" : "<p>No assessment has been made of the availability of homeopathy on the National Health Service.<\/p><p>It is the responsibility of local NHS organisations to make decisions on the commissioning and funding of any healthcare treatments for NHS patients, such as homeopathy, taking account of issues to do with safety, clinical and cost-effectiveness and the availability of suitably qualified/regulated practitioners.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2014-09-04T13:05:54.7306046Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-07-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Homeopathy"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the availability of homeopathy on the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "206797"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answer.dateOfAnswer=2014-09-04&max-date=2014-10-21&answer.answeringMemberPrinted=Jane+Ellison&max-answer.questionFirstAnswered.=2014-09-04T14%3A21%3A02.8013433Z", "page" : 0, "startIndex" : 1, "totalResults" : 12, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}